OUTCOMES AFTER PARS PLANA VITRECTOMY FOR EPIRETINAL MEMBRANES ASSOCIATED WITH TOXOPLASMOSIS

Retina ◽  
2016 ◽  
Vol 36 (9) ◽  
pp. 1713-1717 ◽  
Author(s):  
Ana F. Miranda ◽  
Gabriel Costa de Andrade ◽  
Eduardo A. Novais ◽  
André Maia ◽  
Heloisa Nascimento ◽  
...  
Keyword(s):  
Pars Plana Vitrectomy ◽  
Epiretinal Membranes ◽  
Pars Plana

Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis

Ophthalmology ◽  
1999 ◽  
Vol 106 (6) ◽  
pp. 1086-1090 ◽  
Author(s):  
Sundeep Dev ◽  
William F. Mieler ◽  
Jose S. Pulido ◽  
Robert A. Mittra
Keyword(s):  
Pars Plana Vitrectomy ◽  
Epiretinal Membranes ◽  
Visual Outcomes ◽  
Pars Planitis ◽  
Pars Plana

PARS PLANA VITRECTOMY FOR SYMPTOMATIC EPIRETINAL MEMBRANES IN EYES WITH 20/50 OR BETTER PREOPERATIVE VISUAL ACUITY

Retina ◽  
2015 ◽  
Vol 35 (9) ◽  
pp. 1822-1827 ◽  
Author(s):  
Brian P. Lehpamer ◽  
Petros E. Carvounis
Keyword(s):  
Visual Acuity ◽  
Pars Plana Vitrectomy ◽  
Epiretinal Membranes ◽  
Preoperative Visual Acuity ◽  
Pars Plana

scholarly journals Retinal Complications Associated With Pars Plana Vitrectomy for Macular Holes or Epiretinal Membranes in Eyes With Previous Retinal Detachment Repair

2014 ◽  
Vol 132 (1) ◽  
pp. 118 ◽  
Author(s):  
Ravi S. J. Singh ◽  
Douglas J. Covert ◽  
Christopher R. Henry ◽  
Sandeep K. Bhatia ◽  
Jason Croskrey ◽  
...  
Keyword(s):  
Retinal Detachment ◽  
Pars Plana Vitrectomy ◽  
Epiretinal Membranes ◽  
Macular Holes ◽  
Pars Plana ◽  
Retinal Complications

scholarly journals Intraocular Lens Power Estimation in Combined Phacoemulsification and Pars Plana Vitrectomy in Eyes with Epiretinal Membranes: A Case-Control Study

2015 ◽  
Vol 56 (3) ◽  
pp. 805 ◽  
Author(s):  
Min Kim ◽  
Hyoung Eun Kim ◽  
Dong Hyun Lee ◽  
Hyoung Jun Koh ◽  
Sung Chul Lee ◽  
...  
Keyword(s):  
Intraocular Lens ◽  
Pars Plana Vitrectomy ◽  
Case Control Study ◽  
Power Estimation ◽  
Case Control ◽  
Epiretinal Membranes ◽  
Intraocular Lens Power ◽  
Pars Plana ◽  
Lens Power ◽  
Control Study

A customized posterior scleral reinforcement for myopic macular hole with retinal detachment and posterior staphyloma: A case report

2020 ◽  
pp. 112067212092726 ◽  
Author(s):  
Rino Frisina
Keyword(s):  
Retinal Detachment ◽  
Macular Hole ◽  
Pars Plana Vitrectomy ◽  
Internal Limiting Membrane ◽  
Epiretinal Membranes ◽  
Posterior Staphyloma ◽  
Retinal Reattachment ◽  
Pars Plana ◽  
Posterior Scleral Reinforcement ◽  
Myopic Macular Hole

The author describes a customized posterior scleral reinforcement, its manufacturing method, the rationale of its therapeutic effect, and the surgical technique of its implantation. A 54-year-old female patient with a case history of myopic macular hole with retinal detachment and posterior staphyloma, refractory to pars plana vitrectomy and peeling of internal limiting membrane, underwent posterior scleral reinforcement treatment. Retinal reattachment and macular hole closure were obtained. Best corrected visual acuity increased from light perception to 20/160 Snellen. The pars plana vitrectomy is mandatory to remove vitreoretinal tractions and epiretinal membranes; furthermore, the internal limiting membrane peeling makes retina less rigid. However, it may not be sufficient to allow retinal reattachment and it plays no preventive role in limiting posterior staphyloma progression. The rationale of posterior scleral reinforcement is to reduce retinal stretching, to contain posterior staphyloma, and to limit its progression over time.

Bilateral Pars Plana Vitrectomy for Vitreous Opacities and Epiretinal Membrane in Gaucher Disease

2018 ◽  
Vol 2 (4) ◽  
pp. 235-239 ◽  
Author(s):  
Philip P. Storey ◽  
Jeffrey J. Tan ◽  
Nadim Rayess ◽  
Narsing Rao
Keyword(s):  
Epiretinal Membrane ◽  
Pars Plana Vitrectomy ◽  
Gaucher Disease ◽  
Internal Limiting Membrane ◽  
Effective Treatment Option ◽  
Epiretinal Membranes ◽  
Successful Resolution ◽  
Vitreous Opacities ◽  
Pars Plana ◽  
Lipid Storage Disorder

Purpose: To describe the clinical course of a patient with Gaucher disease, a rare lipid storage disorder, who presented with bilateral visually striking vitreous opacities and epiretinal membranes. Methods: Case report. Results: Pars plana vitrectomy and membrane peel were sequentially performed in both eyes with successful resolution of the opacities and macular puckers, although in one eye, the internal limiting membrane was not initially peeled, and a second surgery was required when the epiretinal membrane rapidly returned. Eight months after surgery, visual acuity improved from 20/150 bilaterally to 20/40 and 20/50 without recurrence of vitreous opacities. Conclusions: Pars plana vitrectomy with membrane peel for patients with vitreous opacities and epiretinal membranes in the setting of Gaucher disease can be an effective treatment option.

Perfluorohexyloctane Endotamponade for Treatment of Subfoveal Hemorrhage

2002 ◽  
Vol 12 (6) ◽  
pp. 534-536 ◽  
Author(s):  
J.B. Jonas ◽  
M. Jäger
Keyword(s):  
Visual Acuity ◽  
Pars Plana Vitrectomy ◽  
Case Series ◽  
Age Related Macular Degeneration ◽  
Subretinal Hemorrhage ◽  
Epiretinal Membranes ◽  
Additional Tool ◽  
Primary Surgery ◽  
Age Related ◽  
Pars Plana

Purpose To report on the use of perfluorohexyloctane as a heavy liquid to temporarily tamponade the fovea for the prevention of recurrent massive subfoveal hemorrhage in patients with exudative age-related macular degeneration (ARMD). Methods The case series comprised seven patients with acute massive subfoveal hemorrhage due to exudative ARMD. The patients underwent pars plana vitrectomy, drainage of the subretinal blood, and foveal endotamponade with perfluorohexyloctane. The perfluorohexyloctane was removed 80.4 ± 38.1 days (median 98 days; range 22–118 days) after the primary surgery in a second pars plana intervention. Results In six patients (85.7%) the subretinal hemorrhage removed during the first pars plana vitrectomy did not recur after removal of perfluorohexyloctane. In the seventh, however, a subretinal hemorrhage re-developed five days after release of perfluorohexyloctane. No large epiretinal membranes were observed. In six eyes (85.7%), the retina remained attached after removal of perfluorohexyloctane but in one eye proliferative vitreoretinopathy developed, with central retinal detachment. After the first pars plana vitrectomy, visual acuity increased slightly but not significantly (p=0.25), from 0.03 ± 0.03 to 0.05 ± 0.07. Intraocular pressure rose from 15.0 ± 1.9 mm Hg to 24.9 ± 16.9 mm Hg. After a follow-up of 69.7 ± 121.0 days after removal of the perfluorohexyloctane, final visual acuity was 0.02 ± 0.04. Conclusions Perfluorohexyloctane may be a useful additional tool for preventing the recurrence of subfoveal re-bleeding in exudative ARMD.

Soloist performance of vitrectomy probe in proliferative diabetic retinopathy

2018 ◽  
Vol 29 (2) ◽  
pp. 251-256 ◽  
Author(s):  
Mohammed M Elwan ◽  
Sherein M Hagras ◽  
Manal A Kasem
Keyword(s):  
Pars Plana Vitrectomy ◽  
Case Series ◽  
Vitreous Hemorrhage ◽  
Epiretinal Membranes ◽  
Corrected Visual Acuity ◽  
Vitreoretinal Traction ◽  
Pars Plana ◽  
Diabetic Vitrectomy ◽  
Anatomic Success

Purpose: To evaluate the feasibility and outcomes of the sole use of 23g pars plana vitrectomy in cases with diabetic vitreous hemorrhage with vitreoretinal traction. Methods: Prospective interventional case series involving patients between January 2013 and January 2018. All eyes underwent 23g pars plana vitrectomy with internal tamponade. Intraoperative parameters including ancillary instruments, the methods used for hemostasis and complications were all recorded. Postoperative parameters including anatomic success rate, functional success, and postoperative complications were recorded and analyzed. Patients were followed up for at least 12 months. Results: A total of 68 eyes of 66 patients were included. Intraoperative ancillary instruments were required in 5 (7.4%) eyes. None of the cases required the use of chandelier illumination, endodiathermy, or scissors. Mean best-corrected visual acuity improved significantly from LogMAR 1.67 ± 0.63 preoperative to 1.22 ± 0.38 at 1-year follow-up (P = 0.005). Functional success was achieved in 37 (54.4%) eyes at 1-year follow-up. Iatrogenic breaks occurred in 3 (4.4%) eyes, vitreous hemorrhage in 4 (5.9%) eyes, and epiretinal membranes in 3 (4.4%) eyes. Repeated vitrectomy was done in 3 (4.4%) eyes. Conclusion: The 23g vitrectomy probe proved to be a safe, effective, and beneficial single tool that could accomplish the diabetic vitrectomy mission exclusively with minimal aid from other instruments in cases with vitreous hemorrhage associated with vitreoretinal traction.

Sign in / Sign up

Export Citation Format

Share Document